Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pathology & Lab Medicine

LCZ696, Novartis‘ new drug is breaking barriers in heart failure, and reducing the risk of death or hospitalization by an impressive 20 percent, an article published by CBS News reports. According to Dr. Clyde Yancy, chief of cardiology at...
According to a Reuters article, a new experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked to trials on humans, which if successful, will result in production of 10,000 emergency doses. With 1,550 dead from the virus in the recent...
According to an article published by Reuters, Eli Lilly and Company has announced an improved experimental drug used to treat psoriasis. The drug, ixekizumab, proved to have significantly greater levels of skin clearance than current generic therapies or...